Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun;18(6):1517-1519.
doi: 10.1111/jth.14844.

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Affiliations
Comment

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Marisa Dolhnikoff et al. J Thromb Haemost. 2020 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1(A)
Figure 1(A)
Diffuse alveolar damage in fatal COVID‐19. (B‐D) Fibrinous microthrombi in small‐sized pulmonary arterioles, observed in 8 of 10 patients.

Comment on

References

    1. Thachil J. The versatile heparin in COVID‐19. J Thromb Haemost. 2020 - PMC - PubMed
    1. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 - PMC - PubMed
    1. Lillicrap D. Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia. J Thromb Haemost. 2020;18(4):786–787. - PMC - PubMed
    1. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. - PMC - PubMed
    1. Mehta P., McAuley D.F., Brown M., et al. COVID‐19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. - PMC - PubMed